Cathy Burgess Discusses Recent FDA Enforcements with The Gray Sheet (Audio)

Cathy Burgess, partner in Alston & Bird’s Health Care Group, addressed recent FDA enforcement actions on data-integrity issues during a panel discussion at the Food and Drug Law Institute. Burgess spoke with The Gray Sheet about the need for more FDA guidance on controls. Listen here.